NuCana Analyst Ratings
NuCana Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/18/2023 | 412.82% | Oppenheimer | → $4 | Reiterates | Outperform → Outperform |
| 05/22/2023 | 412.82% | Oppenheimer | → $4 | Reiterates | Outperform → Outperform |
| 09/22/2022 | 284.62% | Jefferies | $21 → $3 | Maintains | Buy |
| 03/03/2022 | — | Cowen & Co. | Downgrades | Outperform → Market Perform | |
| 11/24/2021 | 1053.85% | HC Wainwright & Co. | $10 → $9 | Maintains | Buy |
| 12/01/2020 | 1182.05% | HC Wainwright & Co. | $15 → $10 | Maintains | Buy |
| 11/24/2020 | 1823.08% | HC Wainwright & Co. | $17 → $15 | Maintains | Buy |
| 10/22/2020 | 2720.51% | Truist Securities | → $22 | Initiates Coverage On | → Buy |
| 08/21/2020 | 2079.49% | HC Wainwright & Co. | $16 → $17 | Maintains | Buy |
| 07/24/2020 | 2464.1% | Oppenheimer | → $20 | Initiates Coverage On | → Outperform |
| 03/11/2020 | 1951.28% | HC Wainwright & Co. | $17 → $16 | Maintains | Buy |
| 11/15/2019 | 2079.49% | HC Wainwright & Co. | $20 → $17 | Reiterates | → Buy |
| 08/19/2019 | 2464.1% | HC Wainwright & Co. | → $20 | Initiates Coverage On | → Buy |
| 10/19/2018 | 4515.38% | Piper Sandler | → $36 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/18/2023 | 412.82% | 奧本海默 | → 4 美元 | 重申 | 跑贏大盤 → 跑贏大盤 |
| 05/22/2023 | 412.82% | 奧本海默 | → 4 美元 | 重申 | 跑贏大盤 → 跑贏大盤 |
| 09/22/2022 | 284.62% | 傑富瑞集團 | 21 美元 → 3 美元 | 維護 | 購買 |
| 2022 年 3 月 3 日 | — | Cowen & Co. | 降級 | 跑贏大盤 → 市場表現 | |
| 11/24/2021 | 1053.85% | HC Wainwright & Co. | 10 美元 → 9 美元 | 維護 | 購買 |
| 12/01/2020 | 1182.05% | HC Wainwright & Co. | 15 美元 → 10 美元 | 維護 | 購買 |
| 11/24/2020 | 1823.08% | HC Wainwright & Co. | 17 美元 → 15 美元 | 維護 | 購買 |
| 2020 年 10 月 22 日 | 2720.51% | 信實證券 | → 22 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 08/21/2020 | 2079.49% | HC Wainwright & Co. | 16 美元 → 17 美元 | 維護 | 購買 |
| 07/24/2020 | 2464.1% | 奧本海默 | → 20 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
| 03/11/2020 | 1951.28% | HC Wainwright & Co. | 17 美元 → 16 美元 | 維護 | 購買 |
| 11/15/2019 | 2079.49% | HC Wainwright & Co. | 20 美元 → 17 美元 | 重申 | → 購買 |
| 08/19/2019 | 2464.1% | HC Wainwright & Co. | → 20 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 10/19/2018 | 4515.38% | 派珀·桑德勒 | → 36 美元 | 啓動覆蓋範圍開啓 | → 超重 |
What is the target price for NuCana (NCNA)?
NuCana（NCNA）的目標價格是多少？
The latest price target for NuCana (NASDAQ: NCNA) was reported by Oppenheimer on August 18, 2023. The analyst firm set a price target for $4.00 expecting NCNA to rise to within 12 months (a possible 412.82% upside). 3 analyst firms have reported ratings in the last year.
奧本海默於2023年8月18日公佈了NuCana（納斯達克股票代碼：NCNA）的最新目標股價。該分析公司將目標股價定爲4.00美元，預計NCNA將在12個月內上漲至412.82％（可能上漲412.82％）。去年有3家分析公司公佈了評級。
What is the most recent analyst rating for NuCana (NCNA)?
NuCana (NCNA) 的最新分析師評級是多少？
The latest analyst rating for NuCana (NASDAQ: NCNA) was provided by Oppenheimer, and NuCana reiterated their outperform rating.
NuCana（納斯達克股票代碼：NCNA）的最新分析師評級由奧本海默提供，NuCana重申了其跑贏大盤的評級。
When is the next analyst rating going to be posted or updated for NuCana (NCNA)?
NuCana（NCNA）的下一次分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NuCana, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NuCana was filed on August 18, 2023 so you should expect the next rating to be made available sometime around August 18, 2024.
分析師在進行了廣泛的研究後得出了股票評級，包括閱讀公開財務報表、與NuCana的高管和客戶交談以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應獲得4個評級。NuCana的最新評級是在2023年8月18日提交的，因此你應該預計下一個評級將在2024年8月18日左右公佈。
Is the Analyst Rating NuCana (NCNA) correct?
NuCana（NCNA）的分析師評級是否正確？
While ratings are subjective and will change, the latest NuCana (NCNA) rating was a reiterated with a price target of $0.00 to $4.00. The current price NuCana (NCNA) is trading at is $0.78, which is within the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但重申了最新的NuCana（NCNA）評級，目標股價爲0.00美元至4.00美元。NuCana（NCNA）目前的交易價格爲0.78美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。